Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Norditropin approved for adults with severe growth hormone deficiency

Nov. 9, 2004

Treatment of multifactor anemia by hypoxia-inducible factor inhibitor

Nov. 9, 2004

X-Ceptor researchers identify potent and selective inverse agonist of ERRalpha

Nov. 8, 2004

Genzyme seeks additional indication for Thyrogen

Nov. 8, 2004

Studies reveal efficacy of pyridoxamine in diabetic nephropathy

Nov. 8, 2004

Low-frequency CERA dosing effective in chronic kidney disease patients

Nov. 8, 2004

Phase II multidose study planned for exenatide LAR in 2005

Nov. 8, 2004

7TM Pharma selects preclinical candidate for obesity

Nov. 5, 2004

FDA approves new Xenical labeling

Nov. 5, 2004

Banyu scientists prepare and test new glucokinase activators

Nov. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...